Yıl: 2018 Cilt: 89 Sayı: 2 Sayfa Aralığı: 66 - 73 Metin Dili: İngilizce İndeks Tarihi: 11-12-2018

Evaluation of platelet activating factor in neonatal calves with sepsis

Öz:
Early diagnosis and treatment of sepsis are very important conditions in patients for their survival. Novel biomarkers such as platelet activating factor (PAF) have been found that it has an important role in sepsis process. The aim of this study is to determine the role of PAF in pathogenesis and the diagnosis importance in calves with sepsis. For this purposes, 30 neonatal calves with sepsis (sepsis group) and 10 healthy neonatal calves (control group) were used. Plasma samples were used to determine the PAF level with using bovine specific ELISA kits. Plasma concentration of PAF was found significantly higher (P < 0.01) in sepsis group compare to control group. We concluded that PAF has an important role in sepsis and it may have diagnostic value in calves with sepsis. Further studies are required to determine the importance of PAF as diagnostic and prognostic biomarker in calves with sepsis and evaluate the concentrations of these biomarker also in other disease states.
Anahtar Kelime:

Konular: Veterinerlik

Sepsis şüphesi bulunan neonatal buzağılarda platelet aktive edici faktörün değerlendirilmesi

Öz:
Sepsisin erken tanısı ve tedavisi, hastaların hayatta kalmaları için çok büyük önem arzeder. Sepsis sürecinde önemli rol oynayan trombosit aktive edici faktör (PAF) gibi yeni biyolojik belirteçler bulunmuştur. Bu çalışmanın amacı sepsisli buzağılarda PAF’ın patogenezdeki rolünü ve diagnostik önemini belirlemektir. Bu amaçla sepsisli 30 yeni doğan buzağı ve 10 sağlıklı neonatal buzağı kullanıldı. Buzağılardan alınan plazma örneklerinde sığır spesifik ELISA kiti kullanılarak PAF plazma konsantrasyonu belirlendi. PAF plazma konsantrasyonu sepsis grubunda kontrol grubuna göre anlamlı derecede yüksekti (P < 0.01). PAF’ın sepsisde önemli bir rolü olduğu ve sepsisli buzağılarda tanısal değeri olabileceği sonucuna varıldı. Öte yandan, sepsisli buzağılarda PAF’ın tanısal ve prognostik önemini belirlemek için diğer biyolojik biyomarkırlarla birlikte değerlendirildiği ileri çalışmalara ihtiyaç olduğu görüldü.
Anahtar Kelime:

Konular: Veterinerlik
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Zimmerman BJ, Granger DN (1992): Reperfusion ınjury. Surgical Clinics of North America, 72, 65-83.
  • Weiss S.J. (1989): Tissuo destruclicn by neutrcphıls. N Engl J Med, 320, 356-376.
  • Tornquist SJ, Rigas J (2010): Interpretation of ruminant leukocyte responses. 307-313. In: Weiss DJ, Wardrop KJ (Ed): Schalm’s Veterinary Hematology. Wiley, Ames, Iowa.
  • Thomas E (2004): Comparative field efficacy study between cefquinome and gentamicin in neonatal calves with clinical signs of septicaemia. Rev Med Vet-Toulouse, 155, 489-493.
  • Szabó C, Wu CC, Mitchell JA, Gross SS, Thiemermann C, Vane JR (1993): Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ. Res, 73, 991-999.
  • Singer M, et al. (2016): The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 315, 801-810.
  • Serhan CN, Haeggstrom JZ, Leslie CC (1996): Lipid mediator networks in cell signaling: Update and impact of cytokines. FASEB J, 10, 1147-1158.
  • Roland L, Drillich M, Iwersen M (2014): Hematology as a diagnostic tool in bovine medicine. Journal of Veterinary Diagnostic Investigation, 26, 592-598.
  • Radostıts OM, Gay CC, Blood DC, Hinchcliff KW (2007): General systemic states and Diseases of the newborn. 39-160. In: Radostıts OM (Ed) Veterinary Medicine: A Textbook of the Diseases of Cattle, Sheep, Pigs, Goats and Horses (9th Ed). Saunders Elsevier, Philadelphia.
  • Ono S, Mochizuki H, Tamakuma S (1996): A clinical study on the significance of plateletactivating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am. J. Surg, 171, 409-415.
  • Ok M (2015): Evaluation of acute phase proteins, some cytokines and hemostatic parameters in dogs with sepsis. Kafkas Univ Vet Fak Derg, 21, 761-766.
  • Narahara H, Johnston JM (1993): Effects of endotoxins and cytokines on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol, 169, 531–7.
  • Munford RS (2005): Sepsis, severe sepsis and septic shock. 906-926. In: Mandell GL, Bennet JE, Dolin R (Ed): Principles And Practice of Infectious Disease. 6th edn. Churchill Livingstone, Philadelphia.
  • Mozes T, Heiligers JP, Tak CJ (1991): Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. J Lipid Mediat, 4, 309–25.
  • Martin GS (2012): Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Review of Anti- Infective Therapy, 10, 701–706.
  • Maeir RV, Hahnel GB, Fletcher JR (1992): Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J. Surg. Res, 52, 258-264.
  • MacKendrick W, Hill N, Hsueh W, Caplan M (1993): Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate, 64, 89-95.
  • Leaver HA, Qu JM, Smith G, Howie A, Ross WB, Yap PL (1990): Endotoxin releases platelet-activating factor from human monocytes in vitro. Immunopharmacology, 20, 105-113.
  • Kurulay F, Çavdar Z (2006): İnflamatuar medyatörlere toplu bir bakış. Genel Tıp Derg, 16, 143-152.
  • Kruse-Elliot KT, Albert DH, Summers JB (1996): Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. Shock, 5, 265-273.
  • Ishii S, Nagase T, Tashiro F (1997): Bronchial hyperactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J, 16, 133–42.
  • Irmak K (2006): The evaluation of coagulation profiles in calves with suspected septic shock. Vet Res Commun, 30, 497-503.
  • Herbertson MJ, Werner HA, Walley KR (1997): Platelet-activating factor antagonism improves ventriculer contractility in endotoxemia. Crit.Care Med, 259, 221-226
  • Hanahan DJ (1986): Platelet activating factor: A biologically active phosphoglyceride. Annu Rev Biochem, 55, 483–509.
  • Grace PA (1994): Ischaemia-reperfusion injury. British J of Surgery, 81, 637-647.
  • Fletcher JR, Disimone AG, Earnest MA (1990): Platelet-activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. Ann. Surg, 211, 312- 316.
  • Fecteau G, Smith BP, George LW (2009): Septicemia and meningitis in the newborn calf. Vet Clin North Am Food Anim Pract, 25, 195-208.
  • Fecteau G (1997): Use of a clinical sepsis score for predicting bacteremia in neonatal dairy calves on a calf rearing farm. Can Vet J, 38, 101104.
  • Faix JD (2013): Biomarkers of sepsis. Critical Reviews in Clinical Laboratory Sciences, 50, 23–36.
  • Doebber TW, Wu MS, Robbıns JC, Choy BM, Chang MN, Shen TY (1985): Platelet activating factor (PAF) involvement in endotoxininduced hypotension in rats. Studies with PAFreceptor antagonist kadsurenone. Biochem. biophys. Res Commun, 127, 799- 808.
  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R (2013): Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med, 41, 580637.
  • Defaux JP, Thonier F, Baroggi N (1993): Involvement of plateletactivating factor (PAF) in endotoxin- or ischaemia-induced intestinal hyperpermeability in the rat. J Lipid Med, 7, 11– 21.
  • Crain MC and Muller B (2007): Biomarkersinrespiratorytract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. European Respiratory Journal, 30, 556–573.
  • Chang SW, Feddersen CO, Henson PM (1987): Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest, 79, 1498– 509.
  • Caplan, MS, Sun, XM, Hseuh, W, Hageman, JR (1990): Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr, 116, 960-964.
  • Caplan, MS, Kelly, A, Hsueh, W (1992): Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor. Pediatr Res, 31, 428-34.
  • Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, SaAnavio F, Bussolino F (1983): The release of platelet-activating factor from human endothelial cells in culture. J Immunol, 131(5):2397–2403.
  • Basoglu A, Baspinar N, Tenori L, Hu X, Yildiz R (2014): NMR Based Metabolomics Evaluation in Neonatal Calves with Acute Diarrhea and Suspected Sepsis: A New Approach for Biomarkers. Metabolomics, 4, 2.
  • Aydogdu U, Guzelbektes H (2018): Effect of colostrum composition on passive calf immunity in primiparous and multiparous dairy cows. Veterinary medicina, 63, 1-11.
  • Aydoğdu U, Coşkun A, Yıldız R, Güzelbekteş H, Şen İ (2018): Changes of hematological parameters and serum iron levels in calves with systemic inflamatory response syndrome. Eurasian J Vet Sci, 34, 56-59.
  • Angus DC (2013): Severe sepsis and septic shock. N Engl J Med, 369.
  • Aldridge BM (1993): Neonatal septicemia in calves: 25 Cases. J Am Vet Med Assoc, 203, 13241329.
APA YILDIZ R, BESLEK M, BEYDİLLİ Y, ÖZÇELİK M M, BİÇİCİ Ö (2018). Evaluation of platelet activating factor in neonatal calves with sepsis. , 66 - 73.
Chicago YILDIZ Ramazan,BESLEK Mustafa,BEYDİLLİ Yasemin,ÖZÇELİK M Merve,BİÇİCİ Özlem Evaluation of platelet activating factor in neonatal calves with sepsis. (2018): 66 - 73.
MLA YILDIZ Ramazan,BESLEK Mustafa,BEYDİLLİ Yasemin,ÖZÇELİK M Merve,BİÇİCİ Özlem Evaluation of platelet activating factor in neonatal calves with sepsis. , 2018, ss.66 - 73.
AMA YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö Evaluation of platelet activating factor in neonatal calves with sepsis. . 2018; 66 - 73.
Vancouver YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö Evaluation of platelet activating factor in neonatal calves with sepsis. . 2018; 66 - 73.
IEEE YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö "Evaluation of platelet activating factor in neonatal calves with sepsis." , ss.66 - 73, 2018.
ISNAD YILDIZ, Ramazan vd. "Evaluation of platelet activating factor in neonatal calves with sepsis". (2018), 66-73.
APA YILDIZ R, BESLEK M, BEYDİLLİ Y, ÖZÇELİK M M, BİÇİCİ Ö (2018). Evaluation of platelet activating factor in neonatal calves with sepsis. Veteriner Hekimler Derneği Dergisi, 89(2), 66 - 73.
Chicago YILDIZ Ramazan,BESLEK Mustafa,BEYDİLLİ Yasemin,ÖZÇELİK M Merve,BİÇİCİ Özlem Evaluation of platelet activating factor in neonatal calves with sepsis. Veteriner Hekimler Derneği Dergisi 89, no.2 (2018): 66 - 73.
MLA YILDIZ Ramazan,BESLEK Mustafa,BEYDİLLİ Yasemin,ÖZÇELİK M Merve,BİÇİCİ Özlem Evaluation of platelet activating factor in neonatal calves with sepsis. Veteriner Hekimler Derneği Dergisi, vol.89, no.2, 2018, ss.66 - 73.
AMA YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö Evaluation of platelet activating factor in neonatal calves with sepsis. Veteriner Hekimler Derneği Dergisi. 2018; 89(2): 66 - 73.
Vancouver YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö Evaluation of platelet activating factor in neonatal calves with sepsis. Veteriner Hekimler Derneği Dergisi. 2018; 89(2): 66 - 73.
IEEE YILDIZ R,BESLEK M,BEYDİLLİ Y,ÖZÇELİK M M,BİÇİCİ Ö "Evaluation of platelet activating factor in neonatal calves with sepsis." Veteriner Hekimler Derneği Dergisi, 89, ss.66 - 73, 2018.
ISNAD YILDIZ, Ramazan vd. "Evaluation of platelet activating factor in neonatal calves with sepsis". Veteriner Hekimler Derneği Dergisi 89/2 (2018), 66-73.